Your browser doesn't support javascript.
Zero COVID-19 infection in inflammatory bowel disease patients: Findings from population-based inflammatory bowel disease registries in Hong Kong and Taiwan.
Mak, Joyce Wing Yan; Weng, Meng-Tzu; Wei, Shu Chen; Ng, Siew Chien.
  • Mak JWY; Department of Medicine and Therapeutics, Institute of Digestive Disease, LKS Institute of Health Science, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.
  • Weng MT; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taiwan.
  • Wei SC; Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taiwan.
  • Ng SC; Department of Medicine and Therapeutics, Institute of Digestive Disease, LKS Institute of Health Science, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.
J Gastroenterol Hepatol ; 36(1): 171-173, 2021 Jan.
Article in English | MEDLINE | ID: covidwho-1032414
ABSTRACT
BACKGROUND AND

AIM:

It is unsure whether inflammatory bowel disease (IBD) is a risk factor for novel coronavirus infection (COVID-19).

METHODS:

IBD patients were identified from population-based databases in Hong Kong and Taiwan from January 21, 2020, until April 15, 2020.

RESULTS:

Total 2954 and 2554 IBD patients were identified in Hong Kong and Taiwan, respectively. None had COVID-19. Pooled analysis showed that 65.3%, 39.1%, 4.3%, and 12.8% IBD patients in Hong Kong and 75.8 %, 51.4 %, 26.1%, and 52.3 % in Taiwan were on 5-aminosalicylates, immunomodulators, corticosteroids, and biologics, respectively.

CONCLUSION:

There were no reported cases of COVID-19 infection amongst IBD patients in Hong Kong and Taiwan. IBD patients should continue their usual medications during the COVID-19 pandemic.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Reviews Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: J Gastroenterol Hepatol Journal subject: Gastroenterology Year: 2021 Document Type: Article Affiliation country: Jgh.15164

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study / Reviews Topics: Long Covid Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: J Gastroenterol Hepatol Journal subject: Gastroenterology Year: 2021 Document Type: Article Affiliation country: Jgh.15164